Loading clinical trials...
Loading clinical trials...
Phase II study of selective intra-arterial infusion of chemotherapy for intraocular retinoblastoma
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
NCT03050268 · Acute Leukemia, Adenomatous Polyposis, and more
NCT04959097 · Retinoblastoma, Retinoblastoma Bilateral, and more
NCT06679634 · Retinoblastoma
NCT03267459 · Retinoblastoma
NCT07136181 · Metastatic Uveal Melanoma, Uveal Melanoma, Metastatic, and more
Stanford University School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions